Pradefovir, CAS [[625095-60-5]]

Produktübersicht

• Artikelname: Pradefovir, CAS [[625095-60-5]]
• Artikelnummer: TGM-T28449
• Hersteller Artikelnummer: T28449
• Alternativnummer: TGM-T28449-1MG,TGM-T28449-2MG,TGM-T28449-5MG,TGM-T28449-10MG,TGM-T28449-25MG,TGM-T28449-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ICN-2001-3 , MB-6866 , ICN-20013 , MB-06866 , Remofovir

Produktbeschreibung

Pradefovir (Remofovir) is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection. Pradefovir is also a liver-targeted prodrug of adefovir. After metabolic activation, Pradefovir was converted to PMEA (9-(2-phosphonylmethoxyethyl)adenine) in human liver microsomes with a K(m) of 60 microM, a maximum rate of metabolism of 228 pmol/min/mg protein, and an intrinsic clearance of about 359 ml/min.

Produkteigenschaften

• Molekulargewicht: 423.79
• Reinheit: 0.975
• CAS Nummer: [625095-60-5]
• Formel: C17H19ClN5O4P
• Target-Kategorie: Cytochromes P450|||HBV

Bilder

T28449